Peru

5 Vaccines Approved for Use in Peru

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: gob.pe
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: digemid.minsa.gob.pe
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: gob.pe

5 in Clinical Trials in Peru

Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries

1 Vaccines with Trials in Peru are No Longer Progressing

RNA

Curevac

CVnCoV

9 trials in 12 countries